About Stada
Stada is a company based in Bad Vilbel (Germany) founded in 1895 was acquired by CapVest in September 2025. The company has 30 employees as of April 01, 2024. Stada has completed 9 acquisitions, including Aqualor, Clare Fischer and Hemofarm.
- Headquarter Bad Vilbel, Germany
- Employees 30 as on 01 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stada Pharma Services India Private Limited
- Date of Incorporation 04 Jul, 2013
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$1.37 M (USD)56.26as on Mar 31, 2023
-
Net Profit
$90.9 K (USD)49.59as on Mar 31, 2023
-
EBITDA
$385.33 K (USD)27.51as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
HSBC
& 10 more
-
Employee Count
30
as on Apr 01, 2024
-
Investments & Acquisitions
Aqualor
& 8 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Stada
Unlock access to complete
Unlock access to complete
Software Development Team
138 people
Leadership Team
45 people
Finance and Accounting
28 people
Sales and Marketing
22 people
Human Resources and Administration
20 people
Legal and Compliance
18 people
Senior Team
15 people
Operations Team
13 people
Unlock access to complete
Funding Insights of Stada
Investors in Stada
Stada has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include HSBC, Deutsche Bank and UniCredit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm managing assets and expanding into equity, credit, and real estate services.
|
Locked | Locked | Locked | |
|
CapVest is recognized as a leading private equity investor.
|
Locked | Locked | Locked | |
|
Private equity investments and portfolio management services are provided by Cinven across various sectors.
|
Locked | Locked | Locked |
Investor details for Stada
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stada
Stada has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Aqualor, Clare Fischer and Hemofarm.
Investment portfolio details for Stada
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of nasal drugs
|
Locked | Locked | 2007 | Locked | |
|
Contract development and manufacturing services for pharmaceutical APIs are provided.
|
Locked | Locked | 2000 | Locked | |
|
Music recording and print services are provided to clients.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Stada
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Stada
Detailed financials for Stada
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stada Comparisons
Peer comparison for Stada
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stada
Detailed competitors of Stada
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stada
Complete news archive for Stada
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stada
Stada was founded in 1895 and raised its 1st funding round 108 years after it was founded.
Stada is headquartered in Bad Vilbel, Germany. It is registered at Bad Vilbel, Hesse, Germany.
Claudio Albrecht is the current CEO of Stada.
As of Apr 01, 2024, the latest employee count at Stada is 30.
Annual revenue of Stada is $1.37M as on Mar 31, 2023.
Stada was founded in 1895 and is based in Bad Vilbel, Germany. Operations are focused on the pharmaceutical sector, where generics and biosimilars are developed and distributed. An extensive portfolio is maintained, encompassing treatments for pain, cholesterol management, stomach ulcers, hypertension, central nervous system disorders, inflammatory conditions, and other areas. Manufacturing and distribution facilities are operated in Germany, the UK, Russia, China, Argentina, and various additional countries.
Stada has made 9 acquisitions, including Aqualor, Clare Fischer, and Hemofarm.
Stada has 11 investors. Key investors include HSBC, Deutsche Bank, UniCredit, Elliott Management, and Commerzbank.